Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
Anna Allué‐Guardia, Rajagopalan Saranathan, John Chan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 735-735
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects
Ngozi Joannes Anyaegbunam, Chijioke Chinedu Anekpo, Zikora Kizito Glory Anyaegbunam, et al.
Microbiological Research (2022) Vol. 264, pp. 127155-127155
Open Access | Times Cited: 50
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice
Fan Yang, Alireza Labani‐Motlagh, José Alejandro Bohórquez, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review
Fatemeh Zeynali Kelishomi, Susan Khanjani, Fatemeh Fardsanei, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
Li Yang, Xiao-meng Li, Hao-yu Duan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
An Exploratory Review of the Potential of Lytic Proteins and Bacteriophages for the Treatment of Tuberculosis
Sibongile Mtimka, Priyen Pillay, Lusisizwe Kwezi, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 570-570
Open Access | Times Cited: 5
Medicinal Plants as Effective Antiviral Agents and Their Potential Benefits
Gabriel Atampugbire, Eureka Adomako, Osbourne Quaye
Natural Product Communications (2024) Vol. 19, Iss. 9
Open Access | Times Cited: 4
Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?
Andreas H. Diacon, Carlos A. Guerrero-Bustamante, Bernd Rosenkranz, et al.
Respiration (2021) Vol. 101, Iss. 1, pp. 1-15
Open Access | Times Cited: 26
Actinobacteriophage Inteins: Host Diversity, Local Dissemination, and Non-Canonical Architecture
Sophia Gosselin, Danielle Arsenault, J. Peter Gogarten
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterization of a novel virulent mycobacteriophage Kashi-SSH1 (KSSH1) depicting genus-specific broad-spectrum anti-mycobacterial activity
Tanmayee Nayak, Anuja Kakkar, Lav Kumar Jaiswal, et al.
Life Sciences (2025), pp. 123546-123546
Closed Access
Genome sequences of four A1 subcluster Mycobacterium smegmatis bacteriophages
Spencer T. Payne, Jayden S. Longhurst, Ester Lázaro, et al.
Microbiology Resource Announcements (2025)
Open Access
Liposomal Mycobacteriophage D29: Therapeutic Efficacy Against a Drug-Resistant Strain of Mycobacterium tuberculosis in an Experimental Study on Inbred Mice and Associated Toxicity Evaluation
Vadim Vadimovich Avdeev, M. A. Vladimirsky, Anastasia G. Samoilova, et al.
PHAGE (2025)
Open Access
Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
Xudong Ouyang, Xiaotian Li, Jinmiao Song, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Activity of Bacteriophage D29 Loaded on Nanoliposomes against Macrophages Infected with Mycobacterium tuberculosis
Ana P. B. Silva, Cesar Augusto Roque‐Borda, Christian Shleider Carnero Canales, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 150-150
Open Access | Times Cited: 7
Feasibility of novel approaches to detect viable Mycobacterium tuberculosis within the spectrum of the tuberculosis disease
Sogol Alebouyeh, Brian Weinrick, Jacqueline M. Achkar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway
Jiajia Bao, Yonglin He, Yang Chun, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0281170-e0281170
Open Access | Times Cited: 5
Experimental Studies of the Liposomal Form of Lytic Mycobacteriophage D29 for the Treatment of Tuberculosis Infection
Vadim Vadimovich Avdeev, Victor Vladimirovich Kuzin, Mikhail Vladimirsky, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1214-1214
Open Access | Times Cited: 5
Phages for the treatment of Mycobacterium species
Christoffel J. Opperman, Justyna Wojno, Wynand J. Goosen, et al.
Progress in molecular biology and translational science (2023), pp. 41-92
Closed Access | Times Cited: 4
Phage therapy to combat mycobacterial infections: a therapeutic perspective
Saurabh Gupta, Ayushi SHARMA, Rasanpreet KAUR, et al.
Minerva Biotechnology and Biomolecular Research (2024) Vol. 35, Iss. 4
Closed Access | Times Cited: 1
Construing the function of N‐terminal domain of D29 mycobacteriophage LysA endolysin in phage lytic efficiency and proliferation
Rutuja Gangakhedkar, Vikas Jain
Molecular Microbiology (2024) Vol. 122, Iss. 2, pp. 243-254
Closed Access | Times Cited: 1
Can We Exploit Inflammasomes for Host-Directed Therapy in the Fight against Mycobacterium tuberculosis Infection?
Lilitha Cebani, Nontobeko E. Mvubu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8196-8196
Open Access | Times Cited: 1
Discovery and characterization of a novel LysinB from F2 sub-cluster mycobacteriophage RitSun
R. G. Arora, Kanika Nadar, Urmi Bajpai
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Lytic Spectra of Tailed Bacteriophages: A Systematic Review and Meta-Analysis
Ivan M. Pchelin, Andrei V. Smolensky, Daniil V. Azarov, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1879-1879
Open Access | Times Cited: 1
Ending tuberculosis: challenges and opportunities
Beth Gilmour, Kefyalew Addis Alene
Frontiers in Tuberculosis (2024) Vol. 2
Open Access | Times Cited: 1
Alternatives to antibiotics in veterinary medicine: considerations for the management of Johne's disease
Laura M. O'Connell, Aidan Coffey, Jim O’Mahony
Animal Health Research Reviews (2023) Vol. 24, Iss. 1, pp. 12-27
Open Access | Times Cited: 3
Endolysin B as a new archetype inM. tuberculosistreatment
Anna Griego, Beatrice Antinori, Andrea Spitaleri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top